Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review

ConclusionsThe addition of drug therapy to EVL improves the efficacy of EVL alone. However, the addition of EVL to β‐blockers and ISMN achieves a non‐significant decrease of rebleeding with no effect on mortality. Although combination therapy with EVL plus β‐blockers ± ISMN is adequate to prevent rebleeding, β‐blockers + ISMN alone may be a valid alternative.

Source: Liver International - January 24, 2014 Category: Gastroenterology Authors: Angela Puente, Virginia Hernández‐Gea, Isabel Graupera, Marta Roque, Alan Colomo, Maria Poca, Carles Aracil, Ignasi Gich, Carlos Guarner, Càndid Villanueva Tags: Review Article Source Type: research